hotspot -WSS

hotspot

author：explore 2025-09-06 01:41:14 - browse：24

Stain of a biopsy specimen of a rhabdoid tumor -- health coverage from STAT — Stain of a biopsy specimen of a rhabdoid tumor. Wikimedia Commons

Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred the cell into murderously rapid growth.

But many tumors don’t have a hyperactive gene. Like the mayhem in “Cat in the Hat,” they are enabled by parental absence. They grow because the genes that are meant to provide discipline, guiding the activity of other genes or self-destructing a cell whose DNA is too damaged, are broken or missing.

These tumors have bedeviled researchers for decades. Restoring or fixing a protein is far harder than breaking it. And that’s bad news for humanity: Cancer is far more likely to be caused by such “tumor-suppressor” genes than by one gene run amok.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： STAT Readout Newsletter: Today's biggest biotech updates

hotspot

entertainment

WSS

CEOs share strategies for surviving biotech slump

2023 STAT Wunderkinds: get to know the winners

ALS groups 'won't be played again' by the FDA, drug sponsors

Beam Therapeutics to lay off 20% of its staff, re

Change Healthcare cyberattack outage could last weeks

Pfizer highlights cancer drugs it thinks could reignite investor interest

entertainment

hotspot

entertainment

Hollywood unions extend contract negotiations for actors

ALS groups 'won't be played again' by the FDA, drug sponsors

Drug repurposing or repositioning? The language matters

Scientists unlock the key to scar

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA warns J&J's Abiomed: We will regulate your software

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

NIH confirmation hearing shows politicization of research

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA does about

hotspot

Medical device lobby: We're tired of waiting on Medicare coverage

STAT Readout Newsletter: Today's biggest biotech updates

STAT Summit: GSK CEO on pharma giant's new direction

Studies point to risks of excluding people with obesity from drug trials

FDA warns J&J's Abiomed: We will regulate your software

Kenai launches with $82 million for Parkinson’s stem cell therapy

hotspot

leisure time

entertainment

hotspot